Category: Finance
-
Precision Neuroscience Company Starts-Up, Raises $500M
A new company is underway developing more precise therapies for psychiatric and neurodegenerative diseases based on genetics and data science.
-
Seed Stage Investors Raise $450M for New Fund
A venture capital company specializing in financing start-up enterprises at their earliest stages says it raised $450 million for its third venture fund.
-
Synthetic Antibody Company Goes Public in $230M Merger
A developer of synthetic antibodies for inflammatory and skin disorders is becoming a public company through a special purpose acquisition-merger.
-
Foundation Plans $1B for Longevity Research
A charitable foundation began work today supporting research on human longevity, with the goal of increasing lifespans to more than 120 years.
-
Infographic – Few Venture Dollars for Women Founders
Despite an increase in venture investment dollars so far this year, investments in new companies started by women continue to lag behind.
-
Off-the-Shelf Stem Cell Company Forms, Gains $72M
A new enterprise developing packaged blood-forming stem cells as therapies for a range of diseases began operations and raised $72 million in venture funds.
-
Gene Therapy Delivery Company Gains $26M in Early Funds
A developer of delivery methods for gene therapies promising greater safety for patients is raising $26 million in its first venture funding round.
-
Animal Genome Biotech Raises $9M in Seed Funds
A company discovering new drugs for a range of diseases based on the genomes of hibernating animals is raising $9 million in seed funds.
-
Infographic – Digital Therapeutics Funding on the Rise
The technology intelligence company CB Insights reported on new investments in digital therapeutics and found a record-setting funding pace this year.
-
Neuroscience Software Company Raises $23M in Early Funds
A company developing neuroscience data collection and analytics tools for clinicians and researchers raised $22.8 million in its first venture round.